We are pleased to report the publication of our recent paper in Frontiers in Immunology. The work provides insights into adaptive immunity with rAAV vector serotypes which will be important in advancing gene therapy safety, vector selection, immunogenicity assessment and better patient selection for AAV gene therapy. Further details about the publication can be accessed via the link.
